Related references
Note: Only part of the references are listed.Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common
Bradley W. Frazee et al.
ANNALS OF EMERGENCY MEDICINE (2018)
In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from US Hospitals and Comparative Activities of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Genes
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis
Lynn E. Connolly et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women A Randomized Clinical Trial
Angela Huttner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
An Assessment of Inappropriate Antibiotic Use and Guideline Adherence for Uncomplicated Urinary Tract Infections
Michael J. Durkin et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Adverse effects of a single dose of gentamicin in adults: a systematic review
Rachel S. Hayward et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from US Medical Centers, 2013 to 2016
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012
Guillermo V. Sanchez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Fosfomycin: Resurgence of an old companion
Sangeeta Sastry et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2016)
In vitro potency of amikacin and comparators against E. coli, K. pneumoniae and P. aeruginosa respiratory and blood isolates
Christina A. Sutherland et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2016)
Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae in elderly and non-elderly women
S. -H. Wie et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Trends in Aminoglycoside Use and Gentamicin-Resistant Gram-Negative Clinical Isolates in US Academic Medical Centers: Implications for Antimicrobial Stewardship
Mera Ababneh et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2012)
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
Kalpana Gupta et al.
CLINICAL INFECTIOUS DISEASES (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
A systematic review and meta-analysis of misuse of antibiotic therapies in the community
P Kardas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Share Paper
